ATE424411T1 - Varianten von säugerprolactin - Google Patents

Varianten von säugerprolactin

Info

Publication number
ATE424411T1
ATE424411T1 AT03729258T AT03729258T ATE424411T1 AT E424411 T1 ATE424411 T1 AT E424411T1 AT 03729258 T AT03729258 T AT 03729258T AT 03729258 T AT03729258 T AT 03729258T AT E424411 T1 ATE424411 T1 AT E424411T1
Authority
AT
Austria
Prior art keywords
variants
prolactin
mammal
prl
mutations
Prior art date
Application number
AT03729258T
Other languages
English (en)
Inventor
Vincent Goffin
Sophie Bernichtein
Paul Kelly
Original Assignee
Inst Nat Sante Rech Med
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Inst Nat Sante Rech Med filed Critical Inst Nat Sante Rech Med
Application granted granted Critical
Publication of ATE424411T1 publication Critical patent/ATE424411T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/2257—Prolactin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/57554—Prolactin
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2217/00—Genetically modified animals
    • A01K2217/05—Animals comprising random inserted nucleic acids (transgenic)

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Endocrinology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Toxicology (AREA)
  • Rheumatology (AREA)
  • Epidemiology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Reproductive Health (AREA)
  • Pain & Pain Management (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
AT03729258T 2002-01-08 2003-01-08 Varianten von säugerprolactin ATE424411T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP02290030A EP1325930A1 (de) 2002-01-08 2002-01-08 Varianten von Säugerprolactin

Publications (1)

Publication Number Publication Date
ATE424411T1 true ATE424411T1 (de) 2009-03-15

Family

ID=8185691

Family Applications (1)

Application Number Title Priority Date Filing Date
AT03729258T ATE424411T1 (de) 2002-01-08 2003-01-08 Varianten von säugerprolactin

Country Status (11)

Country Link
US (1) US7785838B2 (de)
EP (2) EP1325930A1 (de)
JP (1) JP4324477B2 (de)
CN (1) CN100358919C (de)
AT (1) ATE424411T1 (de)
AU (1) AU2003215539B2 (de)
CA (1) CA2472647C (de)
DE (1) DE60326430D1 (de)
ES (1) ES2323233T3 (de)
MX (1) MXPA04006676A (de)
WO (1) WO2003057729A2 (de)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2632331C (en) 2005-12-22 2015-02-10 Vib Vzw Molecules with a beta-aggregating region and their use in inducing protein aggregation
JP5888832B2 (ja) * 2005-12-22 2016-03-22 フラームス・インテルウニフェルシタイル・インステイチュート・フォール・ビオテヒノロヒー・ヴェーゼットウェー（ヴェーイーベー・ヴェーゼットウェー）Ｖｌａａｍｓ Ｉｎｔｅｒｕｎｉｖｅｒｓｉｔａｉｒ Ｉｎｓｔｉｔｕｕｔ Ｖｏｏｒ Ｂｉｏｔｅｃｈｎｏｌｏｇｉｅ Ｖｚｗ（Ｖｉｂ Ｖｚｗ） タンパク質干渉を媒介する手段および方法
EP2129793A1 (de) 2007-03-20 2009-12-09 Institut National De La Sante Et De La Recherche Medicale Konstitutiv aktive mutanten des prolactin-rezeptors
EP2332995A1 (de) * 2009-12-10 2011-06-15 Bayer Schering Pharma Aktiengesellschaft Neutralisierende Prolactinrezeptor-Antikörper und deren therapeutische Verwendung
WO2011151405A1 (en) 2010-06-04 2011-12-08 Institut National De La Sante Et De La Recherche Medicale (Inserm) Constitutively active prolactin receptor variants as prognostic markers and therapeutic targets to prevent progression of hormone-dependent cancers towards hormone-independence
US10920242B2 (en) 2011-02-25 2021-02-16 Recombinetics, Inc. Non-meiotic allele introgression
US9528124B2 (en) 2013-08-27 2016-12-27 Recombinetics, Inc. Efficient non-meiotic allele introgression
EP2530089A1 (de) * 2011-06-03 2012-12-05 Bayer Pharma Aktiengesellschaft Neutralisierender Antikörper Mat3 gegen den Prolactinrezeptor und dessen therapeutische Verwendung
US20150133383A1 (en) * 2012-05-11 2015-05-14 Prorec Bio Ab Method for diagnosis and treatment of prolactin associated disorders
AU2015320738B2 (en) * 2014-09-23 2021-12-02 Acceligen, Inc. Materials and methods for producing animals with short hair
CN113004388A (zh) * 2019-12-20 2021-06-22 三生国健药业（上海）股份有限公司 一种重组人神经生长因子的制备方法

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4767709A (en) * 1984-06-28 1988-08-30 The Johns Hopkins University Growth-related hormones

Also Published As

Publication number Publication date
WO2003057729A2 (en) 2003-07-17
EP1463758A2 (de) 2004-10-06
EP1325930A1 (de) 2003-07-09
US7785838B2 (en) 2010-08-31
EP1463758B1 (de) 2009-03-04
JP4324477B2 (ja) 2009-09-02
MXPA04006676A (es) 2005-03-31
US20060277614A1 (en) 2006-12-07
CA2472647C (en) 2013-04-02
AU2003215539B2 (en) 2009-03-26
DE60326430D1 (de) 2009-04-16
AU2003215539A1 (en) 2003-07-24
JP2005526493A (ja) 2005-09-08
CN1628128A (zh) 2005-06-15
ES2323233T3 (es) 2009-07-09
CN100358919C (zh) 2008-01-02
CA2472647A1 (en) 2003-07-17
WO2003057729A3 (en) 2003-10-16

Similar Documents

Publication Publication Date Title
DE69940063D1 (de) Biphenylsulfonamide als zweifach aktive rezeptor antagonisten von angiotensin und endothelin
NO20003221L (no) Ny G-proteinkoblet reseptor
CY1107005T1 (el) Ετεροπολυκυκλικες ενωσεις και οι χρησεις τους ως ανταγωνιστες των μεταβοτροπικων υποδοχέων του γλουταμικου
DE60335216D1 (de) Adiponektin-rezeptor und dafür kodierendes gen
DE60332320D1 (de) Neues screening-verfahren
DE60326430D1 (de) Varianten von säugerprolactin
EA200300441A1 (ru) Ассоциация антагониста рецептора св1 и сибутрамина, содержащие их фармацевтические композиции и их применение для лечения ожирения
EP1572967A4 (de) Auf il-1-rezeptor beruhende antagonisten sowie herstellungs- und verwendungsverfahren
EA200401309A1 (ru) Тризамещённые гетероарилы и способы их получения и применения
MXPA05002442A (es) Imidazolopiridinas y metodos para la elaboracion y uso de las mismas.
BG101110A (bg) Заместени пиримидинови съединения и тяхното използване
EA200500173A1 (ru) Производные 3,6-дизамещенного азабицикло[3.1.0]гексана в качестве антагонистов мускариновых рецепторов
CO5460266A1 (es) Novedosos analogos de la somatostatina
EA200000198A1 (ru) 2-ациламинопропанамины в качестве антагонистов рецепторов тахикининов
ID30484A (id) Turunan 4-heterosikliksulfonamidil 6 metoksi 5 (2 metoksi fenoksi) 2 piridil-pirimidin, pembuatannya dan penggunaan sebagai antagonis reseptor endotelin
ATE511644T1 (de) Neues screening-verfahren
BR0317363A (pt) Antagonista de npy-5
SE9804274D0 (sv) Novel receptor
DE602004023493D1 (de) Neues screening-verfahren
SE9902763D0 (sv) Novel receptor
DE69936394D1 (de) Nicht-desensibilisierende ampa-rezeptoren
MX2007005824A (es) Agonistas y antagonistas del receptor de somatostatina.

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties